Trials with medicinal products
ESMART (different tumor types) Clinical study in children with cancer into the safety and efficacy of drugs matching a specific DNA alteration in the tumor - open for inclusion
MK-3475-051 pembrolizumab (melanoma, solid tumor, lymphoma) Clinical study with the study drug MK-3475 in children with skin cancer (melanoma), solid tumor or lymphoma - open for inclusion
Ponatinib INCB084344 (leukemia/solid tumors) Clinical study of the safety and efficacy of ponatinib for the treatment of different types of leukemia or solid tumors in children - open for inclusion
RANDOMET (Kidney cancer stage IV) Medical-scientific research into a new treatment for metastatic kidney cancer - open for inclusion
Other trials
DAVINCY (all cancer types) Clinical study of extended use of the drug (fos)aprepitant to prevent chemotherapy-induced nausea and vomiting - open for inclusion
DRUG Access protocol (solid tumors) A national protocol to facilitate access to new anti-cancer drugs and collect data from targeted anti-cancer drugs not yet eligible for reimbursement - open for inclusion
Dynamic FDG-PET Clinical study to evaluate the use of dynamic FDG-PET scan in pediatric oncology - open for inclusion
FIURTT-Study (Kidney Tumors) Clinical study on the effect of short-term fasting before kidney tumor surgery - open for inclusion
FOCUS (all cancer types) Clinical study to optimize dosing of fluconazole in children for the prevention or treatment of invasive fungal infections - open for inclusion
PINOCCHIO (multiple types of cancer) Clinical study in children on the metabolism, distribution and excretion of chemotherapy in the body, also called pharmacokinetics - open for inclusion
Tumor donation in Childhood Cancer patients This study is designed to enable post-mortem tumor donation in children that die from all different types of pediatric solid and brain tumors, to enable research on end-stage disease- open for inclusion
UMBRELLA (renal tumors) Medical-scientific research related to the SIOP-RTSG 2016 UMBRELLA treatment protocol for children and young adults with kidney tumors - open for inclusion